Nelle Lambert
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Nelle Lambert has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
Anne De Leener
ULB Center of Human Genetics Hôpital Erasme Université Libre de Bruxelles (ULB) Brussels Belgium
1 shared publicationBarbara Dessars
ULB Center of Human Genetics Hôpital Erasme Université Libre de Bruxelles (ULB) Brussels Belgium
1 shared publicationBruno Pichon
ULB Center of Human Genetics Hôpital Erasme Université Libre de Bruxelles (ULB) Brussels Belgium
1 shared publicationCamille Perazzolo
Institut de Recherche Interdisciplinaire en Biologie Humaine et Moléculaire (IRIBHM) Université Libre de Bruxelles (ULB) Route de Lennik 808 1070 Brussels Belgium
1 shared publicationCatheline Vilain
ULB Center of Human Genetics Hôpital Erasme Université Libre de Bruxelles (ULB) Brussels Belgium
1 shared publicationDiana Messina
Department of Paediatric Neurology Hôpital Erasme Université Libre de Bruxelles (ULB) Brussels Belgium
1 shared publication
Latest Publications
- 6 June 2014
- Published by Wiley in Autism Research
- Vol. 7 (5) , 617-622
A Familial Heterozygous Null Mutation of MET in Autism Spectrum Disorder
Autism spectrum disorder (ASD) results from interactions of genetic and environmental factors. The MET proto‐oncogene has been identified as a candidate gene for autism susceptibility, and is implicated in neurodevelopment and social brain circuitry. Here, we describe the first case of a familial mutation of MET, consisting of an interstitial genomic deletion removing exons 12 through 15, causing a frameshift and premature stop codon, with evidence of nonsense‐mediated mRNA decay. On the other allele, patients carried the C allele of the MET promoter rs1858830 polymorphism, known to decrease MET expression and previously associated with autism susceptibility. The heterozygous mutation was associated with autism in one patient, and language and social impairment in a sibling. Our observations delineate the phenotypic spectrum associated with a clearly defined, very likely complete loss of function mutation of MET. Incomplete penetrance in this family was consistent with MET as a partial susceptibility gene for ASD. Implication of MET in normal and pathological brain development opens new perspectives for understanding the pathophysiology of autism and for eventual therapeutical clues. Autism Res 2014, 7: 617–622. © 2014 International Society for Autism Research, Wiley Periodicals, Inc.
- 6 June 2014
- Published by Wiley in Autism Research
- Vol. 7 (5) , 617-622
A Familial Heterozygous Null Mutation of MET in Autism Spectrum Disorder
Autism spectrum disorder (ASD) results from interactions of genetic and environmental factors. The MET proto‐oncogene has been identified as a candidate gene for autism susceptibility, and is implicated in neurodevelopment and social brain circuitry. Here, we describe the first case of a familial mutation of MET, consisting of an interstitial genomic deletion removing exons 12 through 15, causing a frameshift and premature stop codon, with evidence of nonsense‐mediated mRNA decay. On the other allele, patients carried the C allele of the MET promoter rs1858830 polymorphism, known to decrease MET expression and previously associated with autism susceptibility. The heterozygous mutation was associated with autism in one patient, and language and social impairment in a sibling. Our observations delineate the phenotypic spectrum associated with a clearly defined, very likely complete loss of function mutation of MET. Incomplete penetrance in this family was consistent with MET as a partial susceptibility gene for ASD. Implication of MET in normal and pathological brain development opens new perspectives for understanding the pathophysiology of autism and for eventual therapeutical clues. Autism Res 2014, 7: 617–622. © 2014 International Society for Autism Research, Wiley Periodicals, Inc.